GlassScriptPhysician profile
Aj Nixon
NPI 1740481670
$593.88
in general payments reported to CMS, 2019-2025
16 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.52 · 2020: $18.53 · 2023: $140 · 2024: $264 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $143.69 | 2024 | Arexvy, Bexsero, Shingrix |
| Abbvie INC. | $101.81 | 2023-2025 | |
| Becton, Dickinson and Company | $50.00 | 2023 | Bd Safetyglide |
| Lilly USA, LLC | $41.46 | 2024-2025 | Mounjaro, Kisunla |
| Amgen INC. | $35.12 | 2023-2024 | Prolia, Evenity |
| Exact Sciences Corporation | $34.66 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $29.54 | 2024-2025 | |
| Heartflow, INC. | $25.35 | 2025 | |
| Bioventus LLC | $23.52 | 2019 | |
| Integra Lifesciences Corporation | $18.53 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.94 | 2024 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $17.37 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $15.48 | 2024 | Proquad, Gardasil, Capvaxive |
| Novo Nordisk INC | $13.70 | 2024 | Wegovy |
| Dexcom, INC. | $13.00 | 2023 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.71 | 2023 | Airduo Digihaler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aj Nixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.